Utah Medical Products (NASDAQ:UTMD - Get Free Report) posted its earnings results on Thursday. The medical instruments supplier reported $0.94 earnings per share for the quarter, Zacks reports. Utah Medical Products had a net margin of 32.34% and a return on equity of 10.50%. The company had revenue of $9.95 million during the quarter.
Utah Medical Products Stock Performance
UTMD stock traded down $0.04 on Wednesday, reaching $56.38. The company's stock had a trading volume of 10,448 shares, compared to its average volume of 18,571. The business has a fifty day simple moving average of $56.03 and a two-hundred day simple moving average of $56.87. Utah Medical Products has a 12-month low of $51.26 and a 12-month high of $71.96. The firm has a market cap of $183.24 million, a PE ratio of 15.07 and a beta of 0.28.
Utah Medical Products Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 2nd. Investors of record on Wednesday, September 17th will be paid a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a yield of 2.16%. The ex-dividend date is Wednesday, September 17th. Utah Medical Products's payout ratio is 32.62%.
Institutional Trading of Utah Medical Products
An institutional investor recently bought a new position in Utah Medical Products stock. Jane Street Group LLC purchased a new stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 5,653 shares of the medical instruments supplier's stock, valued at approximately $317,000. Jane Street Group LLC owned 0.17% of Utah Medical Products at the end of the most recent reporting period. Institutional investors and hedge funds own 69.60% of the company's stock.
Utah Medical Products Company Profile
(
Get Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Featured Stories
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access